References
- [accessed 2022 Nov 7]. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.
- Ali JK, Riches JC. The impact of the COVID-19 pandemic on oncology care and clinical trials. Cancers Basel. 2021;13(23):5924. doi:10.3390/cancers13235924.
- Bakouny Z, Labaki C, Bhalla S, Schmidt AL, Steinharter JA, Cocco J, Tremblay DA, Awad MM, Kessler A, Haddad RI, et al. Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study. Ann Oncol. 2022;33(8):836–8. doi:10.1016/j.annonc.2022.04.071.
- Berruti AS, Schaaf RC, Jones EA, Ridgway E, Dumont RL, Leiby B, Sancimino C, Yi M, Molholm S. Notes from an epicenter: navigating behavioral clinical trials on autism spectrum disorder amid the COVID-19 pandemic in the Bronx. Trials. 2022;23(1):691. doi:10.1186/s13063-022-06635-9.
- Lasch F, Guizzaro L, Aguirre Davila L, Muller-Vahl K, Koch A. Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological yale global tic severity scale based on the CANNA-TICS study. Pharm Stat. 2021;20(3):675–91. doi:10.1002/pst.2100.
- Tan AC, Ashley DM, Khasraw M. Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic. Clin Cancer Res. 2020;26(13):3100–3. doi:10.1158/1078-0432.CCR-20-1364.
- https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency.
- Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857–72. doi:10.1002/(SICI)1097-0258(19980430)17:8<857:AID-SIM777>3.0.CO;2-E.
- https://www.instituteforgovernment.org.uk/charts/uk-government-coronavirus-lockdowns.
- Khemiri H, Ayouni K, Triki H, Haddad-Boubaker S. SARS-CoV-2 infection in pediatric population before and during the delta (B.1.617.2) and omicron (B.1.1.529) variants era. Virol J. 2022;19(1):144. doi:10.1186/s12985-022-01873-4.
- Smit L, Redfern A, Murray S, Lishman J, van der Zalm MM, van Zyl G, Verhagen LM, de Vos C, Rabie H, Dyk A, et al. SARS-CoV-2 in children and their accompanying caregivers: implications for testing strategies in resource limited hospitals. Afr J Emerg Med. 2022;12(3):177–82. doi:10.1016/j.afjem.2022.04.007.
- Kiely M, Mansour T, Brousseau N, Rafferty E, Paudel YR, Sadarangani M, Svenson LW, Robinson JL, Gagneur A, Driedger SM, et al. COVID-19 pandemic impact on childhood vaccination coverage in Quebec, Canada. Hum Vaccin Immunother. 2022;18(1):2007707. doi:10.1080/21645515.2021.2007707.